Tranexamic Acid Tablet
Product Images NDC 71335-2695

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 71335-2695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352695)

This text appears to be a pharmaceutical label detailing information for tablets containing 650 mg of tranexamic acid USP for oral administration. It includes details such as NDC code, adult dosage instructions, storage conditions, and information for pharmacists on dispensing. The label also mentions repackaging information and advises keeping the medication out of reach of children. The text suggests referring to the package insert for dosage details and complete product information.*

FDA Label Image

Figure-1-tranexamic-acid.jpg (Tranexamic Acid Figure 1)

Mean Menstrual Blood Loss (mL) is being measured in a study comparing the effectiveness of Tranexamic Acid Tablets at a dosage of 3900 mg/day in 3- and 6-cycle studies versus a placebo. The study will track blood loss during different menstrual cycles to evaluate the impact of treatment. The data presented shows blood loss levels at different treatment periods for each cycle.*

FDA Label Image

Tranexamic-acid-structure (Tranexamic Acid Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.